Patents by Inventor Misuzu Tsukagawa

Misuzu Tsukagawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8071141
    Abstract: A composition for preventing or ameliorating multiple risk factor syndrome involving visceral fat-type obesity, diabetes mellitus, hyperlipemia and hypertension, which comprises at least one member selected from the group consisting of a licorice hydrophobic extract, a turmeric extract, a clove extract, and a cinnamon extract.
    Type: Grant
    Filed: August 18, 2005
    Date of Patent: December 6, 2011
    Assignee: Kaneka Corporation
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa
  • Patent number: 7888388
    Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.
    Type: Grant
    Filed: September 18, 2008
    Date of Patent: February 15, 2011
    Assignee: Kaneka Corporation
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Mikio Kitahara, Kaku Nakagawa, Shiro Kitamura, Yasuyoshi Ueda, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
  • Patent number: 7524975
    Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.
    Type: Grant
    Filed: October 11, 2002
    Date of Patent: April 28, 2009
    Assignee: Kaneka Corporation
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Mikio Kitahara, Kaku Nakagawa, Shiro Kitamura, Yasuyoshi Ueda, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
  • Publication number: 20090036519
    Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.
    Type: Application
    Filed: September 18, 2008
    Publication date: February 5, 2009
    Inventors: Tatsumasa MAE, Misuzu Tsukagawa, Mikio Kitahara, Kaku Nakagawa, Shiro Kitamura, Yasuyoshi Ueda, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
  • Publication number: 20080188549
    Abstract: The present invention has its object to provide a specific compound derived from a naturally occurring substance, and a composition for the prevention and/or treatment of metabolic syndrome and insulin resistance syndrome which comprises that as an active ingredient, easily and efficiently. The present invention relates to a composition for the prevention and/or treatment of metabolic syndrome and a composition for the prevention and/or treatment of insulin resistance syndrome, each of which comprises, as an active ingredient, at least one compound selected from among the compound represented by the formula (1), compounds represented by the formula (4) and compounds represented by the formula (5), or a salt or ester thereof.
    Type: Application
    Filed: February 8, 2006
    Publication date: August 7, 2008
    Applicant: Kaneka Corporation
    Inventors: Hozumi Tanaka, Shinichi Yokota, Misuzu Tsukagawa, Tatsumasa Mae, Minpei Kuroda, Yoshihiro Mimaki
  • Publication number: 20080132544
    Abstract: An object of the present invention is to provide a peroxisome proliferator-activated receptor ? (PPAR?) ligand derived from a natural product and to provide a composition for prevention or improvement of insulin resistant syndrome, diabetes mellitus, obesity, or visceral fat obesity, characterized by comprising the ligand as an active ingredient. The present invention provides a PPAR? ligand comprising as an active ingredient, at least one compound selected from the group consisting of coumaperine and derivatives thereof. The present invention also provides a composition for prevention or improvement of insulin resistant syndrome, diabetes mellitus, obesity, or visceral fat obesity comprising the compound as an active ingredient.
    Type: Application
    Filed: December 19, 2005
    Publication date: June 5, 2008
    Applicant: KANEKA CORPORATION
    Inventors: Mitsuaki Kitano, Misuzu Tsukagawa, Eisaku Konishi, Tatsumasa Mae, Kazunori Hosoe
  • Publication number: 20070082068
    Abstract: An object of the present invention is to provide IL-8 production promoters derived from safe food materials and to provide immunostimulants or preventive or treating agents of infectious disease comprising the IL-8 production promoter. The present inventors have found that a composition comprising, as an active ingredient, at least one plant extract from peppermint, dokudami (houttuynia herb), or licorice promotes IL-8 production, and that a composition comprising, as an active ingredient, at least one compound selected from the group consisting of ?-humulene, ?-pinene, ?-pinene, and L-menthol promotes IL-8 production. These IL-8 production promoters can be used in foods and drinks supplemented with immunostimulants or preventive or treating agents of infectious disease.
    Type: Application
    Filed: November 17, 2004
    Publication date: April 12, 2007
    Inventors: Hideo Satsu, Tatsumasa Mae, Misuzu Tsukagawa, Mikio Kitahara, Shinichi Yokota, Makoto Shimizu
  • Patent number: 7090874
    Abstract: The object of the present invention is to provide PPAR? ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR? ligand as an active agent. The present invention relates to a ligand for peroxisome proliferator-activated receptor which comprises curcumin or its derivatives. The composition according to the present invention, which comprises the PPAR? ligand as an active agent is useful for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity.
    Type: Grant
    Filed: January 8, 2004
    Date of Patent: August 15, 2006
    Assignee: Kaneka Corporation
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
  • Publication number: 20050287233
    Abstract: The invention aims at a composition for preventing or ameliorating multiple risk factor syndrome involving visceral fat-type obesity, diabetes mellitus, hyperlipemia and hypertension, which comprises at least one member selected from the group consisting of a licorice hydrophobic extract, a turmeric extract, a clove extract, and a cinnamon extract.
    Type: Application
    Filed: August 18, 2005
    Publication date: December 29, 2005
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa
  • Publication number: 20050014819
    Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenyl flavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.
    Type: Application
    Filed: October 11, 2002
    Publication date: January 20, 2005
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Mikio Kitahara, Kaku Nakagawa, Shiro Kitamura, Yasuyoshi Ueda, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
  • Publication number: 20040253329
    Abstract: The object of the present invention is to provide PPAR&ggr; ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR&ggr; ligand as an active agent.
    Type: Application
    Filed: January 8, 2004
    Publication date: December 16, 2004
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
  • Publication number: 20040142049
    Abstract: The object of the present invention is to provide a composition having a TNF production inhibitory effect and TNF production inhibitors, which raise no adverse effect or safety problem, can inhibit any excessive production of TNF and is useful in the prevention or amelioration of various TNF-mediated diseases, such as chronic inflammatory diseases, acute inflammatory diseases, infectious inflammatory diseases, autoimmune diseases, and allergic diseases.
    Type: Application
    Filed: March 24, 2004
    Publication date: July 22, 2004
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Mikio Kitahara, Kaku Nakagawa
  • Publication number: 20040028751
    Abstract: The invention aims at a composition for preventing or ameliorating multiple risk factor syndrome involving visceral fat-type obesity, diabetes mellitus, hyperlipemia and hypertension,
    Type: Application
    Filed: September 11, 2003
    Publication date: February 12, 2004
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa
  • Publication number: 20030147979
    Abstract: The object of the present invention is to provide PPAR&ggr; ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR&ggr; ligand as an active agent.
    Type: Application
    Filed: October 23, 2002
    Publication date: August 7, 2003
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida